Baseline gut microbiome ecology predicts long-term fat mass loss after bariatric surgery: evidence for a thrifty <i>Bifidobacterium</i> phenotype.
Higher baseline levels of Bifidobacterium spp. may be linked to less fat mass loss after bariatric surgery, suggesting a need for personalized approaches based on gut microbiome profiles.
Where it sits
this study against the rest of the matrixyl corpusSummary and findings
This study evaluated the relationship between baseline gut microbiome ecology and long-term fat mass loss in patients undergoing bariatric surgery. It involved 85 patients with severe obesity and 21 normal-weight controls, assessing microbiome diversity and fat mass changes over 24 months. Findings indicated that higher baseline levels of Bifidobacterium were associated with less fat mass loss post-surgery.
Abstract
Bariatric surgery (BS) induces weight loss, but long-term success involves complex host-microbiome interactions. We evaluated the longitudinal impact of BS, microbiome resilience, and Mediterranean Diet (MedDiet) adherence up to 24 months. This prospective observational study included 85 patients with severe obesity undergoing BS and 21 normal-weight healthy controls (HC). MedDiet adherence (PREDIMED) was assessed before surgery. Fecal microbiota (16S-rRNA sequencing) and metabolomics (<sup>1</sup>H-NMR spectroscopy) were analyzed at baseline and at 1-, 6-, and 12-months post-BS. Clinical outcomes and fat mass, evaluated by bioimpedanciometry, were tracked up to 24 months. At baseline, patients exhibited higher microbial Shannon diversity than controls (<i>p</i> = 0.041), alongside a dysfunctional microbiome and metabolome characterized by a higher Firmicutes/Bacteroidetes ratio and elevated levels of branched-chain amino acids (<i>p</i> < 0.0001). Ordinary Least Squares (OLS) regression analysis revealed that MedDiet adherence and type 2 diabetes status significantly modulated baseline diversity. At 12 months post-BS, the gut ecosystem underwent profound remodeling, characterized by depletion of <i>Bifidobacterium</i> spp. and an increase in butyrate levels (<i>p</i> < 0.0001), establishing a novel adaptive state distinct from HC. Baseline gut ecology significantly conditioned long-term BS outcomes: patients in the highest quartile of baseline <i>Bifidobacterium</i> spp. lost significantly less fat mass at 24 months than those in the lowest (6.6% vs. 13.2%, <i>p</i> = 0.010). High baseline <i>Bifidobacterium</i> abundance paradoxically acts as a "thrifty microbiome," potentially maximizing energy harvest and limiting surgery-induced fat loss. Overall, BS induces adaptive microbiome restoration rather than true normalization, highlighting the potential for precision interventions prior to surgery.
Background
This paper addresses the complex interactions between bariatric surgery outcomes and gut microbiome ecology. Prior research has indicated that the gut microbiome plays a role in weight management and metabolic health, but the specific contributions of different microbial populations remain unclear. Understanding these interactions is crucial for optimizing bariatric surgery outcomes and developing personalized pre-surgical interventions.
Methods
This was a prospective observational study involving 85 patients with severe obesity undergoing bariatric surgery and 21 normal-weight healthy controls. The study assessed MedDiet adherence using the PREDIMED questionnaire and analyzed fecal microbiota through 16S-rRNA sequencing and metabolomics via 1H-NMR spectroscopy at baseline and at 1, 6, and 12 months post-surgery. Clinical outcomes, including fat mass measured by bioimpedanciometry, were tracked up to 24 months.
Results
At baseline, patients showed a higher microbial Shannon diversity than controls (p=0.041) and a higher Firmicutes/Bacteroidetes ratio (p<0.0001). At 12 months post-surgery, there was a significant increase in butyrate levels (p<0.0001) and a depletion of Bifidobacterium spp. Notably, patients in the highest quartile of baseline Bifidobacterium spp. lost significantly less fat mass at 24 months compared to those in the lowest quartile (6.6% vs. 13.2%, p=0.010).
Interpretation
The findings suggest that baseline gut microbiome composition, particularly levels of Bifidobacterium, may influence long-term weight loss outcomes following bariatric surgery. While the statistical significance of the results is clear, the clinical relevance of a 6.6% vs. 13.2% fat mass loss may vary among practitioners. Limitations include the observational nature of the study and potential confounding factors such as diet and metabolic status, which could affect the outcomes.
Key findings
- Patients in the highest quartile of baseline Bifidobacterium spp. lost 6.6% fat mass at 24 months compared to 13.2% in the lowest quartile, p=0.010.
- At baseline, patients exhibited higher microbial Shannon diversity than controls, p=0.041.
- The Firmicutes/Bacteroidetes ratio was elevated in patients, p<0.0001.
- At 12 months post-BS, there was an increase in butyrate levels, p<0.0001.
Limitations
- Observational study design limits causal inference.
- Small sample size of 85 patients may affect generalizability.
- Lack of randomization could introduce bias.
- Short follow-up period of 24 months may not capture long-term effects.